Updated Jul 16, 2026
Kingsley Stuart A has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $30K.
Stuart A. Kingsley is a director of Indivior Pharmaceuticals, Inc., as disclosed in an SEC filing with CIK 0001369067 dated January 28, 2026. The filing reports no insider purchases or sales by Kingsley during the reporting period. This biography is derived from the SEC context; additional professional background is not provided in the filing.
| Role | Director |
|---|---|
| Notability | 35/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 6.5K | $0.00 | |
| 2026-03-11 | INDV | Indivior Pharmaceuticals, Inc. | P — Open-market purchase | 940 | $31.86 | $30K |
| 2026-01-28 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 3.7K | $0.00 |
Stuart A. Kingsley is a director of Indivior Pharmaceuticals, Inc., as disclosed in an SEC filing with CIK 0001369067 dated January 28, 2026. The filing reports no insider purchases or sales by Kingsley during the reporting period. This biography is derived from the SEC context; additional professional background is not provided in the filing.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($30K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kingsley Stuart A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.